Given the 10-year outcomes of UK FAST-Forward presented at ESTRO, how have you expanded the use of ultra-hypofractionation in your practice?
Should all breast cancer patients receive 5 fractions of radiation, or are there still some who need three weeks of treatment? Any hint that real-world data differs from the trial, especially regarding cosmesis?
Answer from: Radiation Oncologist at Community Practice
We offer 5 fractions to all early-stage breast cancer patients. If technically suitable, the preferred option is APBI; otherwise, Fast-Forward 26 Gy in 5, ensuring dose homogeneity as specified in the protocol.